東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Personalized medicine as innovation ...

Kichko, Katharina.

Linked to FindBook

Google Book

Amazon

博客來

Personalized medicine as innovation = what can Germany learn from the USA /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Personalized medicine as innovation/ by Katharina Kichko.
Reminder of title:	what can Germany learn from the USA /
Author:	Kichko, Katharina.
Published:	Wiesbaden :Springer Fachmedien Wiesbaden : : 2019.,
Description:	xxv, 354 p. :ill., digital ;24 cm.
[NT 15003449]:	Personalized Medicine Background -- The United States of America as Early Knower -- Germany as Follower -- Further Implementation of Personalized Medicine in Germany Based on Learnings from the U.S.
Contained By:	Springer eBooks
Subject:	Medical innovations. -
Online resource:	https://doi.org/10.1007/978-3-658-27843-4
ISBN:	9783658278434

Personalized medicine as innovation = what can Germany learn from the USA /
Kichko, Katharina.

Personalized medicine as innovationwhat can Germany learn from the USA /[electronic resource] :by Katharina Kichko. - Wiesbaden :Springer Fachmedien Wiesbaden :2019. - xxv, 354 p. :ill., digital ;24 cm. - Gesundheitsmanagement und gesundheitsokonomik,2523-7667. - Gesundheitsmanagement und gesundheitsokonomik..

Personalized Medicine Background -- The United States of America as Early Knower -- Germany as Follower -- Further Implementation of Personalized Medicine in Germany Based on Learnings from the U.S.

Katharina Kichko supports the first Personalized Medicine learnings as she provides an approach overview in general as well as reimbursement and regulatory policies in particular. In focus stays analysis of the current Personalized Medicine in the U.S. and Germany as well as its preconditions for a wider implementation in the medical practice. Results have shown that the U.S. - as early knower - have the most projects as well as personalized drugs and therapies, while Germany - as a follower - has a significant number of projects and personalized products and more to come in future. Contents Personalized Medicine Background The United States of America as Early Knower Germany as Follower Further Implementation of Personalized Medicine in Germany Based on Learnings from the U.S. Target Groups Students and lecturers in health management Practitioners in the field of healthcare About the Author Katharina Kichko has written this book within her PhD program at the University of Greifswald.

ISBN: 9783658278434

Standard No.: 10.1007/978-3-658-27843-4doiSubjects--Topical Terms:

605994
Medical innovations.

LC Class. No.: RA418.5.M4 / K534 2019

Dewey Class. No.: 610.28

Personalized medicine as innovation = what can Germany learn from the USA /
LDR:02269nmm a2200337 a 4500 001 2193211
003 DE-He213
005 20191218133139.0
006 m d
007 cr nn 008maaau
008 200514s2019 gw s 0 eng d
020 $a 9783658278434 $q (electronic bk.)
020 $a 9783658278427 $q (paper)
024 7 $a 10.1007/978-3-658-27843-4 $2 doi
035 $a 978-3-658-27843-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RA418.5.M4 $b K534 2019
072 7 $a KCQ $2 bicssc
072 7 $a BUS069000 $2 bisacsh
072 7 $a KCVJ $2 thema
082 0 4 $a 610.28 $2 23
090 $a RA418.5.M4 $b K46 2019
100 1 $a Kichko, Katharina. $3 3414200
245 1 0 $a Personalized medicine as innovation $h [electronic resource] : $b what can Germany learn from the USA / $c by Katharina Kichko.
260 $a Wiesbaden : $b Springer Fachmedien Wiesbaden : $b Imprint: Springer Gabler, $c 2019.
300 $a xxv, 354 p. : $b ill., digital ; $c 24 cm.
490 1 $a Gesundheitsmanagement und gesundheitsokonomik, $x 2523-7667
505 0 $a Personalized Medicine Background -- The United States of America as Early Knower -- Germany as Follower -- Further Implementation of Personalized Medicine in Germany Based on Learnings from the U.S.
520 $a Katharina Kichko supports the first Personalized Medicine learnings as she provides an approach overview in general as well as reimbursement and regulatory policies in particular. In focus stays analysis of the current Personalized Medicine in the U.S. and Germany as well as its preconditions for a wider implementation in the medical practice. Results have shown that the U.S. - as early knower - have the most projects as well as personalized drugs and therapies, while Germany - as a follower - has a significant number of projects and personalized products and more to come in future. Contents Personalized Medicine Background The United States of America as Early Knower Germany as Follower Further Implementation of Personalized Medicine in Germany Based on Learnings from the U.S. Target Groups Students and lecturers in health management Practitioners in the field of healthcare About the Author Katharina Kichko has written this book within her PhD program at the University of Greifswald.
650 0 $a Medical innovations. $3 605994
650 1 4 $a Health Economics. $3 820895
650 2 4 $a Public Health. $3 624351
650 2 4 $a Innovation/Technology Management. $3 1565353
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Gesundheitsmanagement und gesundheitsokonomik. $3 3332039
856 4 0 $u https://doi.org/10.1007/978-3-658-27843-4
950 $a Economics and Finance (Springer-41170)